.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Practical Application of Recent Clinical Data for Immunotherapy in NSCLC

EP. 1: Practical Application of Recent Clinical Data for Immunotherapy in NSCLC

October 10th 2018

EP. 2: Upfront PD-1 Inhibitor Monotherapy in Advanced NSCLC

October 10th 2018

EP. 3: Immunotherapy + Chemotherapy in Nonsquamous NSCLC

October 10th 2018

EP. 4: Combining Chemotherapy & Immunotherapy in Squamous NSCLC

October 10th 2018

EP. 5: TMB as a Predictive Biomarker in NSCLC

October 10th 2018

EP. 6: Treating Relapsed/Refractory NSCLC After I-O Therapy

October 10th 2018

EP. 7: Continuing/Re-Challenging With I-O Therapy in NSCLC

October 10th 2018

EP. 8: Experience With I-O Therapies in Second-Line NSCLC

October 10th 2018

EP. 9: Immunotherapy in Locally Advanced NSCLC

October 10th 2018

EP. 10: Managing Pneumonitis in NSCLC

October 10th 2018

EP. 11: PD-L1 Expression in NSCLC

October 10th 2018

EP. 12: I-O Therapy Versus Surgery or Chemotherapy in NSCLC

October 10th 2018

EP. 13: Immunotherapy in NSCLC: Audience Q&A

October 10th 2018